Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-10-02 Purchase | 2023-10-04 5:35 pm | Immunome Inc. | IMNM | SIEGALL CLAY B President and CEO | 169,204 | $5.91 | $999,996 | 319,636 (Direct) | View |
2023-10-02 Purchase | 2023-10-04 5:32 pm | Immunome Inc. | IMNM | Turner Bruce Chief Strategy Officer | 42,300 | $5.91 | $249,993 | 42,300 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-25 Option Award | 2024-04-29 8:14 pm | N/A 2034-04-24 | Immunome Inc. | IMNM | SWAIN SANDRA M Director | 25,737 | $0 | 25,737 (Direct) | View |
2024-02-20 Option Award | 2024-02-21 9:10 pm | N/A 2034-02-19 | Immunome Inc. | IMNM | Horn Kinney CHIEF BUSINESS OFFICER | 300,000 | $0 | 300,000 (Direct) | View |
2024-01-31 Option Award | 2024-01-31 8:53 pm | N/A 2034-01-30 | Immunome Inc. | IMNM | Rosett Max EVP, OPERATIONS & INTERIM CFO | 175,000 | $0 | 175,000 (Direct) | View |
2024-01-31 Option Award | 2024-01-31 8:50 pm | N/A 2034-01-30 | Immunome Inc. | IMNM | Stoneman Sandra G. CHIEF LEGAL OFFICER & GC | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2024-01-04 5:40 pm | N/A N/A | Immunome Inc. | IMNM | Lapetina Bob PAO and VP Finance & Corporate | 0 | $0 | 52,947 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 5:37 pm | N/A 2034-01-01 | Immunome Inc. | IMNM | SCHAFER CAROL Director | 32,934 | $0 | 32,934 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 7:28 pm | N/A 2033-12-12 | Immunome Inc. | IMNM | Roberts Phil Noland Chief Technology Officer | 275,000 | $0 | 275,000 (Direct) | View |
2023-12-01 Option Award | 2023-12-05 9:08 pm | N/A 2033-11-30 | Immunome Inc. | IMNM | Higgins Jack Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |
2023-11-07 Option Award | 2023-11-09 4:25 pm | N/A 2033-11-06 | Immunome Inc. | IMNM | BIENAIME JEAN JACQUES Director | 40,696 | $0 | 40,696 (Direct) | View |
Ownership | 2023-11-09 4:23 pm | N/A N/A | Immunome Inc. | IMNM | BIENAIME JEAN JACQUES Director | 0 | $0 | 7,615 (Direct) | View |
2023-10-27 Option Award | 2023-10-31 6:35 pm | N/A 2033-10-26 | Immunome Inc. | IMNM | Barchas Isaac Director | 41,538 | $0 | 41,538 (Direct) | View |
2023-10-27 Option Award | 2023-10-31 6:32 pm | N/A 2033-10-26 | Immunome Inc. | IMNM | Boylan James P Director | 41,538 | $0 | 41,538 (Direct) | View |
2023-10-27 Option Award | 2023-10-31 6:30 pm | N/A 2033-10-26 | Immunome Inc. | IMNM | Lechleider Robert Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2023-10-12 9:56 pm | N/A N/A | Immunome Inc. | IMNM | Barchas Isaac See remarks | 0 | $0 | 2,910,893 (Direct) | View |
Ownership | 2023-10-12 6:36 pm | N/A N/A | Immunome Inc. | IMNM | Rosett Max SVP Operations | 0 | $0 | 193,417 (Direct) | View |
Ownership | 2023-10-12 6:33 pm | N/A 2032-06-23 | Immunome Inc. | IMNM | Higgins Jack Chief Scientific Officer | 0 | $0 | 198,564 (Direct) | View |
Ownership | 2023-10-04 5:34 pm | N/A N/A | Immunome Inc. | IMNM | SIEGALL CLAY B President and CEO | 0 | $0 | 3,677,476 (Direct) | View |
Ownership | 2023-10-04 5:29 pm | N/A 2033-05-14 | Immunome Inc. | IMNM | Turner Bruce Chief Strategy Officer | 0 | $0 | 349,740 (Direct) | View |
2023-10-02 Option Award | 2023-10-04 5:28 pm | N/A N/A | Immunome Inc. | IMNM | PRENDERGAST FRANKLYN G Director | 60,840 | $0 | 198,565 (Direct) | View |
2023-10-02 Option Award | 2023-10-04 5:28 pm | N/A 2032-09-26 | Immunome Inc. | IMNM | PRENDERGAST FRANKLYN G Director | 137,725 | $1.35 | 198,565 (Direct) | View |
2023-10-02 Option Award | 2023-10-03 5:50 pm | N/A N/A | Immunome Inc. | IMNM | RAPP MICHAEL Director | 253,806 | $5.91 | 1,279,914 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 5:05 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | RAPP MICHAEL Director | 6,500 | $0 | 6,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 5:01 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | Stoneman Sandra G. General Counsel and CLO | 56,000 | $0 | 56,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:58 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | Roche Corleen M. Chief Financial Officer | 58,000 | $0 | 58,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:57 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | ROBINSON MATTHEW K Chief Technology Officer | 58,000 | $0 | 58,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:56 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | Sarma Purnanand D President and CEO | 166,500 | $0 | 166,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:55 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | Lefenfeld Michael Director | 6,500 | $0 | 6,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:54 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | LAMATTINA JOHN L Director | 6,500 | $0 | 6,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:52 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | BARON RICHARD A Director | 6,500 | $0 | 6,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:51 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | PRENDERGAST FRANKLYN G Director | 6,500 | $0 | 6,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:48 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | WAGENHEIM PHILIP Director | 6,500 | $0 | 6,500 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:47 pm | N/A 2033-06-08 | Immunome Inc. | IMNM | Giesing Dennis H Chief Development Officer | 50,000 | $0 | 50,000 (Direct) | View |
2023-01-15 Option Award | 2023-01-17 06:30 am | N/A N/A | Immunome Inc. | IMNM | WAGENHEIM PHILIP Director | 8,750 | $4 | 406,147 (Direct) | View |